Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Pål, Johansen"'
Autor:
Ásdís Hjálmsdóttir, Fabio Hasler, Ying Waeckerle-Men, Agathe Duda, María Pilar López-Deber, Maria Pihlgren, Marija Vukicevic, Thomas M. Kündig, Pål Johansen
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-12 (2024)
Abstract Vaccines generally require T lymphocytes for B-cell activation and immunoglobulin class switching in response to peptide or protein antigens. In the absence of T cells, limited IgG class switch takes place, germinal centers are short-lived,
Externí odkaz:
https://doaj.org/article/277c02fabbda4e7584e0111980478e83
Publikováno v:
Frontiers in Allergy, Vol 5 (2024)
ObjectivesPeanut allergy is an IgE-mediated food allergy that is associated with asthma in certain patients. With increasing prevalence, its great impact on the quality of life, and a lack of treatment options, the need for new therapy options is a g
Externí odkaz:
https://doaj.org/article/a09e238f53c84bceb7d1b7c072b22888
Autor:
Lara Šošić, Marta Paolucci, Agathe Duda, Fabio Hasler, Senta M. Walton, Thomas M. Kündig, Pål Johansen
Publikováno v:
Immunity, Inflammation and Disease, Vol 10, Iss 3, Pp n/a-n/a (2022)
Abstract Introduction Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), substantial effort has been made to gain knowledge about the immunity elicited by infection or vaccination. Methods We studied the kinetics
Externí odkaz:
https://doaj.org/article/f917de0087e14f71a1de856b676ca37b
Autor:
Alexandra Chabot, Gabriela Senti, Iris Erdmann, Bettina M. Prinz, Brunello Wüthrich, Lara Šošić, Thomas M. Kündig, Pål Johansen
Publikováno v:
Frontiers in Allergy, Vol 3 (2022)
BackgroundSubcutaneous venom immunotherapy (VIT) represents an effective treatment against bee venom allergy. However, it involves long treatment times, high costs, and the risk of adverse events (AEs). Shorter, safer, and cheaper treatment options a
Externí odkaz:
https://doaj.org/article/60f0105985564c1a941a0abd78ba3b93
Autor:
Ying Waeckerle-Men, Zuzanna K. Kotkowska, Géraldine Bono, Agathe Duda, Isabel Kolm, Eleni M. Varypataki, Beat Amstutz, Michael Meuli, Anders Høgset, Thomas M. Kündig, Cornelia Halin, Peter Sander, Pål Johansen
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Conventional vaccines are very efficient in the prevention of bacterial infections caused by extracellular pathogens due to effective stimulation of pathogen-specific antibodies. In contrast, considering that intracellular surveillance by antibodies
Externí odkaz:
https://doaj.org/article/0bcefb35bffe44a18ecac599fa99313f
Publikováno v:
STAR Protocols, Vol 2, Iss 4, Pp 100824- (2021)
Summary: For a cytopathic virus such as severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), the neutralization capacity of serum from convalescent or vaccinated persons or of therapeutic antibodies can be tested on adherent cell cultur
Externí odkaz:
https://doaj.org/article/9ce0322952ee43a49fdb7208a3df74bb
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/821a893492164ee1a2a8df2239c8db6a
Publikováno v:
Expert Review of Clinical Immunology. :1-25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a5132b676974318bb6b4783e04e5190
https://doi.org/10.1080/1744666x.2023.2209319
https://doi.org/10.1080/1744666x.2023.2209319
Autor:
Yasmin K. Adlany, Lara Šošić, Gabriela Senti, Claudia C.V. Lang, Brunello Wüthrich, Thomas M. Kündig, Pål Johansen
Publikováno v:
Journal of Allergy and Clinical Immunology: Global. 2:43-50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1dd661a9b0793d90bf6123c2dcdb2b36
https://doi.org/10.1016/j.jacig.2022.09.007
https://doi.org/10.1016/j.jacig.2022.09.007
Autor:
Eleni Maria Varypataki, Fabio Hasler, Ying Waeckerle-Men, Sarah Vogel-Kindgen, Anders Høgset, Thomas M. Kündig, Bruno Gander, Cornelia Halin, Pål Johansen
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Cytotoxic T lymphocytes (CTLs) are key players in fighting cancer, and their induction is a major focus in the design of therapeutic vaccines. Yet, therapeutic vaccine efficacy is limited, in part due to the suboptimal vaccine processing by antigen-p
Externí odkaz:
https://doaj.org/article/c0096178e37541498f79e584f063610e